Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Oxygenta Pharmaceutical Financial Results

Oxygenta Pharmaceutical Limited reported its audited financial results for the year ended March 31, 2026. The company also announced key board appointments and auditor changes.

Source

BSE filing, NSE: SSORGS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Oxygenta Pharmaceutical Ltd: key numbers

Share price
₹47.96
Market cap
₹177.4 Cr
Revenue (annual)
₹113.0 Cr
Net profit (annual)
₹-17.57 Cr
P/E (TTM)
-13.1×Sector 46.1×
Promoter holding
56.54%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Oxygenta Pharmaceutical Ltd

All →

Other financial results announcements

All →